Biomedical informatics for optimised treatment of infectious diseases

EuResistEuResist is organising a workshop within the IST 2006 event (Helsinki 21-23 November) on the use of biomedical informatics for optimised treatment of infectious diseases.

The workshop aims at offering a panoramic view of the state of the art of models utilising genetic and clinical information for optimisation of treatment, with a background on infectious diseases. It addresses IT, physical-mathematic and bio-medical communities.

You can have your say, comment or suggest a contribution within September 15 clicking on the workshop description here

PROVISIONAL PROGRAM:
Chairman: Maurizio Zazzi (Biologia molecolare, University of Siena, Italy).

  • Introduction: "Challenges for optimization of treatment of infectious diseases". Maurizio Zazzi
  • "Improved prediction of response to antiretroviral combination therapy using evolutionary models". Andre Altman (Computational biology, Max Planck I. Saarbrücken, Germany)
  • "Jensen-Shannon semi-supervised learning and its application to clinical HIV data". Michal ROSEN-ZVI (IBM Haifa Research Labs, Israel)
  • "GRID computing for best treatment prediction". Peter Sloot - C.A. Boucher (Computational Science, University of Amsterdam, The Nederland)
  • "Pharmacogenomics and pharmainformatics for improving medicinal treatments: the INFOBIOMED experience". Ferran Sanz (GRIB, IMIM-PRBB-UPF, Spain).

    For further information, please visit:

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...